BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 30761794)

  • 1. [The effectiveness of the integrated approach to the treatment of chronic prostatitis, including in patients with benign prostatic hyperplasia].
    Zhiborev AB; Martov AG
    Urologiia; 2018 Oct; (4):81-87. PubMed ID: 30761794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathophysiological aspects of utilization of local physiotherapy device mavit in combined treatment of patients with chronic prostatitis and symptomatic prostatic adenoma].
    Zhiborev BN; Zhiborev AB; Rakcheev BIu
    Urologiia; 2011; (6):36, 38-42. PubMed ID: 22448479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practical use of Adenoprosin in combination therapy in men with lower urinary tract symptoms].
    Kasyan G R; Khodyreva L A; Grigoryan B L; Dyakov V V
    Urologiia; 2024 Mar; (1):61-70. PubMed ID: 38650408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.
    Sacco E; Bientinesi R; Marangi F; Totaro A; D'Addessi A; Racioppi M; Pinto F; Vittori M; Bassi P
    BJU Int; 2012 Dec; 110(11 Pt C):E837-44. PubMed ID: 22712582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of bioregulatory peptides in the treatment of men with benign prostatic hyperplasia and chronic prostatitis].
    Kuzmenko AV; Vinnik YY; Kuzmenko VV; Gyaurgiev TA
    Urologiia; 2021 Jun; (3):70-74. PubMed ID: 34251104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Response to Thermobalancing Therapy Enabled by Therapeutic Device in Men with Non-Malignant Prostate Diseases: BPH and Chronic Prostatitis.
    Aghajanyan IG; Allen S
    Diseases; 2016 Apr; 4(2):. PubMed ID: 28933398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.
    Nickel JC; Elhilali M; Vallancien G;
    BJU Int; 2005 Mar; 95(4):571-4. PubMed ID: 15705082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between TCM syndrome types and clinical symptoms of benign prostatic hyperplasia with chronic prostatitis].
    Huang XF; Ning KQ; Wang Q; Liu T; He Y; Xue JG; Dai LQ; Zhu YK
    Zhonghua Nan Ke Xue; 2017 Dec; 23(12):1111-1115. PubMed ID: 29738184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
    van Vuuren SP; Heyns CF; Zarrabi AD
    BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH).
    Gandaglia G; Briganti A; Gontero P; Mondaini N; Novara G; Salonia A; Sciarra A; Montorsi F
    BJU Int; 2013 Aug; 112(4):432-41. PubMed ID: 23650937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
    Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
    Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [LUTS in BPH patients with histological prostatitis before and after transurethral resection of the prostate].
    Huang XH; Qin B; Liang YW; Wu QG; Li CZ; Wei GS; Ji HC; Liang YB; Chen HQ; Guan T
    Zhonghua Nan Ke Xue; 2013 Jan; 19(1):35-9. PubMed ID: 23469659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.
    Kwon JK; Han JH; Choi HC; Kang DH; Lee JY; Kim JH; Oh CK; Choi YD; Cho KS
    BJU Int; 2016 Feb; 117(2):316-22. PubMed ID: 25807886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benign Prostatic Hyperplasia Treatment with New Physiotherapeutic Device.
    Allen S; Aghajanyan IG
    Urol J; 2015 Nov; 12(5):2371-6. PubMed ID: 26571324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship Between Chronic Periodontitis and Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia.
    Hyun H; Park YW; Kwon YC; Cho BK; Lee JH
    Int Neurourol J; 2021 Mar; 25(1):77-83. PubMed ID: 33504135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.